An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder

Author： Wigal Sharon B   Raja Pooja   Shukla Ankita  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lisdexamfetamine Dimesylate: In Attention-Deficit Hyperactivity Disorder in Adults

By Weber Juliane   Siddiqui M. Asif A.  

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine dimesylate: a guide to its use in attention-deficit hyperactivity disorder

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 10, 2010-10 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder

By Steer Christopher  

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 691-705

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine: a guide to its use in attention-deficit hyperactivity disorder in children

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 7, 2007-07 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite